FSD Pharma Inc C.HUGE

Assembly

[Chuckie18]

The shareholders concerned shall ask the votes of the following 5 candidates, Anthony Durkacz, Zeeshan Saeed, Nitin Kaushal and Lawrence Latowsky, as directors of FSD, and shall ultimately apply for proxies to be used by the Assembly.

[Chuckie18]

The shareholders concerned plan to issue a final circulary containing details on the meeting as well as instructions for completing and returning proxies and voting instructions for use by the shareholders concerned.

[Chuckie18]

The concerned shareholders shall issue a final circular containing the content of the meeting as well as guidance about the fulfillment and return of proxies and voting instructions on the shares in question.

[Chuckie18]

Durkacz and Saeed, founding managers and two interested shareholders, addressed the lack of achievement in November 2020 as share prices hit fresh lows and outlined what they considered to be a successful strategic purchasing opportunity ("Strategic Operation"). They were surprised that Dr. Bokahari did not want to take account of the opportunity and in December 2020 sought to rethink Dr

[Chuckie18]

Although the relative value of a strategic opportunity, which between management and the board may easily be discussed and resolved, could well have been clearly contested. The Directors concerned were soon disturbed by the management of the FSD and Dr. Bokhari (other than Mr. Durkacz and Mr. Saeed). Their issues have grown over the course of time.

[Chuckie18]

After the reluctance of Board members to attend both a Board meeting on 22 December and 30 December Board meetings, Mr. Durkacz and Mr.Saeed spoke about a company's continuing collapse following an aggressive impediment to the CEO and other Board Members. The shareholders in question decided that a resolution was made to hold a conference of special shareholders to vote, sooner rather and

[Chuckie18]

These pending fees and costs are entirely contradictory with the terms, performance and loss of shareholder interest of the Board of Directors and Dr Bokhari's tenure. Dr Bokhariand Board shall receive from a corporation in dispute the largest possible payment until it has no ability, regardless of the interest of shareholders, to repay itself

[Chuckie18]

On 16 December 2020, Mr. Durkacz and Mr. Saeed sent an email to the members of the Board requesting a dialogue on the strategic arrangement. Larry Kaiser, an elected member of the Boards of Directors, requested a Board meeting and recommended that Dr Bokharire schedule a call by 18 December 2020. Dr. Bokharic canceled the Management Board on 18 December 2020 without any explanation.

[Chuckie18]

The Court also ordered Dr. Bokhari, as requested by the concerned shareholders not to act as chairman of the meeting. The Conference will now be held by a neutral person fairly and orderly.

[Chuckie18]

The board members who encourage him to destroy the shares of the firm. The stock price dropped by more than 97%. On October 29, 2018, following Dr. Bokhari's appointment as Intermediate Manager and market capital of the firm decreased by more than $ 500 million